BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38533538)

  • 1. CXCR4-Targeted Macrophage-Derived Biomimetic Hybrid Vesicle Nanoplatform for Enhanced Cancer Therapy through Codelivery of Manganese and Doxorubicin.
    Jang Y; Cho YS; Kim A; Zhou X; Kim Y; Wan Z; Moon JJ; Park H
    ACS Appl Mater Interfaces; 2024 Apr; 16(14):17129-17144. PubMed ID: 38533538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outer membrane vesicle-wrapped manganese nanoreactor for augmenting cancer metalloimmunotherapy through hypoxia attenuation and immune stimulation.
    Luo S; Yang Y; Chen L; Kannan PR; Yang W; Zhang Y; Zhao R; Liu X; Li Y; Kong X
    Acta Biomater; 2024 Jun; 181():402-414. PubMed ID: 38734282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. pH-sensitive tumor-tropism hybrid membrane-coated nanoparticles for reprogramming the tumor microenvironment and boosting the antitumor immunity.
    Zhang J; Wei L; Ma X; Wang J; Liang S; Chen K; Wu M; Niu L; Zhang Y
    Acta Biomater; 2023 Aug; 166():470-484. PubMed ID: 37253416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic reinforcement of immunogenic cell death and transformation of tumor-associated macrophages via an M1-type macrophage membrane-camouflaged ferrous-supply-regeneration nanoplatform.
    Wang Y; Xu H; Wang D; Lu Y; Zhang Y; Cheng J; Xu X; Chen X; Li J
    Acta Biomater; 2024 Jan; 174():358-371. PubMed ID: 38092253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intelligent Nanoplatform Integrating Macrophage and Cancer Cell Membrane for Synergistic Chemodynamic/Immunotherapy/Photothermal Therapy of Breast Cancer.
    Zhang S; Chen W; Zhou Y; Zheng X; Fu Y; Liu H; Wan Z; Zhao Y
    ACS Appl Mater Interfaces; 2023 Dec; 15(51):59117-59133. PubMed ID: 38091266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulating the immunosuppressive tumor microenvironment to enhance breast cancer immunotherapy using pH-responsive hybrid membrane-coated nanoparticles.
    Gong C; Yu X; Zhang W; Han L; Wang R; Wang Y; Gao S; Yuan Y
    J Nanobiotechnology; 2021 Feb; 19(1):58. PubMed ID: 33632231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenic Hybrid Nanovesicles of Liposomes and Tumor-Derived Nanovesicles for Cancer Immunochemotherapy.
    Hu M; Zhang J; Kong L; Yu Y; Hu Q; Yang T; Wang Y; Tu K; Qiao Q; Qin X; Zhang Z
    ACS Nano; 2021 Feb; 15(2):3123-3138. PubMed ID: 33470095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A homologous-targeting cGAS-STING agonist multimodally activates dendritic cells for enhanced cancer immunotherapy.
    Wang P; Wang Y; Li H; Wang M; Wang Y; Wang X; Ran L; Xin H; Ma J; Tian G; Gao W; Zhang G
    Acta Biomater; 2024 Mar; 177():400-413. PubMed ID: 38336268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supramolecular Peptide Amphiphile Nanospheres Reprogram Tumor-associated Macrophage to Reshape the Immune Microenvironment for Enhanced Breast Cancer Immunotherapy.
    Xiao Q; Huang J; Wang X; Chen Z; Zhang W; Liu F; Li J; Yang Z; Zhan J; Cai Y
    Small; 2024 May; 20(21):e2307390. PubMed ID: 38100300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage-cancer hybrid membrane-coated nanoparticles for targeting lung metastasis in breast cancer therapy.
    Gong C; Yu X; You B; Wu Y; Wang R; Han L; Wang Y; Gao S; Yuan Y
    J Nanobiotechnology; 2020 Jun; 18(1):92. PubMed ID: 32546174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineered Bacterial Biomimetic Vesicles Reprogram Tumor-Associated Macrophages and Remodel Tumor Microenvironment to Promote Innate and Adaptive Antitumor Immune Responses.
    Zheng P; He J; Fu Y; Yang Y; Li S; Duan B; Yang Y; Hu Y; Yang Z; Wang M; Liu Q; Zheng X; Hua L; Li W; Li D; Ding Y; Yang X; Bai H; Long Q; Huang W; Ma Y
    ACS Nano; 2024 Mar; 18(9):6863-6886. PubMed ID: 38386537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor microenvironment-activated cancer cell membrane-liposome hybrid nanoparticle-mediated synergistic metabolic therapy and chemotherapy for non-small cell lung cancer.
    Zhang W; Gong C; Chen Z; Li M; Li Y; Gao J
    J Nanobiotechnology; 2021 Oct; 19(1):339. PubMed ID: 34689761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A manganese-phenolic network platform amplifying STING activation to potentiate MRI guided cancer chemo-/chemodynamic/immune therapy.
    Pang X; Fu C; Chen J; Su M; Wei R; Wang Y; Lin W; Wei X; Jiang X; Yang X; Yang H; Wang J; Yang R
    Biomater Sci; 2023 May; 11(11):3840-3850. PubMed ID: 37074080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage-derived biomimetic nanoparticles enhanced SDT combined with immunotherapy inhibited tumor growth and metastasis.
    Chen S; Ma T; Wang J; Liang S; Liao H; Tan W; Chen M; Zhou X; Xu Y; Wang L; Niu C
    Biomaterials; 2024 Mar; 305():122456. PubMed ID: 38184961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting and repolarizing M2-like tumor-associated macrophage-mediated MR imaging and tumor immunotherapy by biomimetic nanoparticles.
    Chong L; Jiang YW; Wang D; Chang P; Xu K; Li J
    J Nanobiotechnology; 2023 Oct; 21(1):401. PubMed ID: 37907987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrazide-manganese coordinated multifunctional nanoplatform for potentiating immunotherapy in hepatocellular carcinoma.
    Hou G; Qian J; Guo M; Xu W; Wang J; Wang Y; Suo A
    J Colloid Interface Sci; 2022 Dec; 628(Pt B):968-983. PubMed ID: 36037718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Manganese-Based Nanoactivator Optimizes Cancer Immunotherapy
    Hou L; Tian C; Yan Y; Zhang L; Zhang H; Zhang Z
    ACS Nano; 2020 Apr; 14(4):3927-3940. PubMed ID: 32298077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage cell membrane infused biomimetic liposomes for glioblastoma targeted therapy.
    Mendanha D; Vieira de Castro J; Casanova MR; Gimondi S; Ferreira H; Neves NM
    Nanomedicine; 2023 Apr; 49():102663. PubMed ID: 36773669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nanoselenium-coating biomimetic cytomembrane nanoplatform for mitochondrial targeted chemotherapy- and chemodynamic therapy through manganese and doxorubicin codelivery.
    Xiao J; Yan M; Zhou K; Chen H; Xu Z; Gan Y; Hong B; Tian G; Qian J; Zhang G; Wu Z
    J Nanobiotechnology; 2021 Jul; 19(1):227. PubMed ID: 34330298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage-derived exosome-mimetic hybrid vesicles for tumor targeted drug delivery.
    Rayamajhi S; Nguyen TDT; Marasini R; Aryal S
    Acta Biomater; 2019 Aug; 94():482-494. PubMed ID: 31129363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.